Company page

Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc. (ticker: FNAM) is a public company based in the United States, with a market capitalization of approximately $1.33 billion. The company focuses on advancements in genomics and related technologies. As a publicly traded entity, it operates within the American market, providing opportunities for investors interested in the biotechnology sector.